TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+31.35%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$249M
AUM Growth
+$249M
(+16%)
Cap. Flow
+$27.8M
Cap. Flow
% of AUM
11.14%
Top 10 Holdings %
Top 10 Hldgs %
63.51%
Holding
54
New
28
Increased
6
Reduced
4
Closed
14
Top Buys
| 1 |
AbbVie
ABBV
|
$24.4M |
| 2 |
Eli Lilly
LLY
|
$21.7M |
| 3 |
argenx
ARGX
|
$16.9M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$15.3M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$15M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$28.6M |
| 2 |
Baxter International
BAX
|
$25.1M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$14.7M |
| 4 |
Merck
MRK
|
$13.7M |
| 5 |
Medtronic
MDT
|
$13M |
Sector Composition
| 1 | Healthcare | 88.73% |
| 2 | Consumer Staples | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
51
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-377,708
| Closed | -$6.13M |
|
|
HZNP
52
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-261,500
| Closed | -$28.6M |
|
|
AVDL
53
Avadel Pharmaceuticals
AVDL
$1.42B
| – | – |
-148,355
| Closed | -$1.45M |
|
54
Novavax
NVAX
$1.2B
| – | – |
0
| – | – |
|